However, significant weight reboundoften exceeding baselineoccurs in 40-80% of users within one year of discontinuation
Ritz P, Vaurs C, Barigou M, et al
Now, a month later, the pain and stiffness are almost completely gone, and I am able to move around a lot more freely
In the following material, we summarized recent evidence linking UA with the risk of arterial hypertension, CAD, AF and HF
[PubMed] [Google Scholar] Seif S
Implementation Barriers and Access to Care Although newer obesity pharmacotherapies demonstrate substantial efficacy, their real-world population-level impact is strongly influenced by cost, insurance coverage, and health-system capacity [101]